Administration of adjuvant chemotherapy for stage II‐III colon cancer patients: An European population‐based study
Abstract
The advantage of adjuvant chemotherapy (ACT) for treating Stage III colon cancer patients is well established and widely accepted. However, many patients with Stage III colon cancer do not receive ACT. Moreover, there are controversies around the effectiveness of ACT for Stage II patients. We investigated the administration of ACT and its association with overall survival in resected Stage II (overall and stratified by low‐/high‐risk) and Stage...
Paper Details
Title
Administration of adjuvant chemotherapy for stage II‐III colon cancer patients: An European population‐based study
Published Date
Dec 4, 2017
Volume
142
Issue
7
Pages
1480 - 1489
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History